CH235478A - Process for the production of a preparation from the blood sugar lowering hormone of the pancreas. - Google Patents

Process for the production of a preparation from the blood sugar lowering hormone of the pancreas.

Info

Publication number
CH235478A
CH235478A CH235478DA CH235478A CH 235478 A CH235478 A CH 235478A CH 235478D A CH235478D A CH 235478DA CH 235478 A CH235478 A CH 235478A
Authority
CH
Switzerland
Prior art keywords
solution
preparation
production
blood sugar
sugar lowering
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellsc Farbenindustrie
Original Assignee
Ig Farbenindustrie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Farbenindustrie Ag filed Critical Ig Farbenindustrie Ag
Publication of CH235478A publication Critical patent/CH235478A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

  

  



  Verfahren zur Herstellung eines Präparates aus dem   blutzuckersenkenden    Hormon der Bauchspeicheldr se.



   Gegenstand des vorliegenden   Zusatz-    patentes ist ein Verfahren zur Herstellung eines PrÏparates aus dem blutzuckersenken  denHormonderBauchspeicheldrüse,welches    dadurch gekennzeichnet ist, da? man ds nach dem Schweizer Patent   Nr.    219800 erhaltene InsulinprÏparat mit Magnesiumchlorid, welches in Wasser gelöst ist, umsetzt.



   Beispiel :
10   g    eines nach dem Schweizer Patent Nr. 219800 erhaltenen InsulinprÏparates werden in 2 Liter 0,5%iger Trichlorbutylalkohollösung durch Zusatz von 12, 5   cm3      n-Salzsäure    in L¯sung gebracht. Man gibt 1, 3 g Magnesiumchlorid und 15 g Kochsalz zu und versetzt dann mit 500 cm3 einer L¯sung, die 14, 4 g   sekundares      Natriumphos-    phat + 8 cm3 n-Natronlauge in 0,   5 %    iger   Trichlorbutylalkohollosung enthält.    Man erhält eine Suspension, die in   1    cm3 40 Einheiten Insulin enthält und ein   pu    von zirka 7 aufweist.



   Das so erhaltene protrahierend wirkende Insulinpräparat l¯st sich auf Zusatz von    Salzsäure. Aus dieser Losung fällt Natron-    lauge einen Niederschlag aus, der bei weiterem Zusatz von Lauge wieder in Lösung geht.  



   PATENTANSPRUCH :
Verfahren zur Herstellung eines PrÏparates aus dem blutzuckersenkenden Hormon der   Bauspeiohel'drüse,dadurch    gekennzeichnet, dass man das nach dem Schweizer Patent Nr. 219800 erhaltene   Insulinpräparat    mit   Magnesiumehlorid,    welches in Wasser   gelât    ist, umsetzt.



   Die so erhaltene Suspension lost sich auf Zusatz von Salzsaure. Aus dieser Losung fällt Natronlauge einen Niederschlag aus, der bei weiterem Zusatz von Lauge wieder in Lösung geht. 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.





  



  Process for the production of a preparation from the blood sugar lowering hormone of the pancreas.



   The subject of the present additional patent is a process for the production of a preparation from the blood sugar lowering hormone pancreas, which is characterized by the fact that? the insulin preparation obtained according to Swiss Patent No. 219800 is reacted with magnesium chloride, which is dissolved in water.



   Example:
10 g of an insulin preparation obtained according to Swiss Patent No. 219800 are dissolved in 2 liters of 0.5% trichlorobutyl alcohol solution by adding 12.5 cm3 of normal hydrochloric acid. 1.3 g of magnesium chloride and 15 g of sodium chloride are added and then 500 cm3 of a solution containing 14.4 g of secondary sodium phosphate + 8 cm3 of sodium hydroxide solution in 0.5% trichlorobutyl alcohol are added. A suspension is obtained which contains 40 units of insulin in 1 cm3 and has a pu of approximately 7.



   The protracting insulin preparation obtained in this way can be obtained by adding hydrochloric acid. A precipitate separates out of this solution, caustic soda, which goes back into solution with further addition of caustic.



   PATENT CLAIM:
Process for the production of a preparation from the blood sugar lowering hormone of the Bauspeiohel'drüse, characterized in that the insulin preparation obtained according to Swiss Patent No. 219800 is reacted with magnesium chloride, which is dissolved in water.



   The suspension thus obtained dissolves on the addition of hydrochloric acid. From this solution, sodium hydroxide solution separates out a precipitate, which goes back into solution with further addition of caustic solution.

** WARNING ** End of DESC field could overlap beginning of CLMS **.



 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung eines Präparates aus dem blutzuckersenkenden Hormon der Bauchspeicheldr se. Process for the production of a preparation from the blood sugar lowering hormone of the pancreas. Gegenstand des vorliegenden Zusatz- patentes ist ein Verfahren zur Herstellung eines PrÏparates aus dem blutzuckersenken denHormonderBauchspeicheldrüse,welches dadurch gekennzeichnet ist, da? man ds nach dem Schweizer Patent Nr. 219800 erhaltene InsulinprÏparat mit Magnesiumchlorid, welches in Wasser gelöst ist, umsetzt. The subject of the present additional patent is a process for the production of a preparation from the blood sugar lowering hormone pancreas, which is characterized by the fact that? the insulin preparation obtained according to Swiss Patent No. 219800 is reacted with magnesium chloride, which is dissolved in water. Beispiel : 10 g eines nach dem Schweizer Patent Nr. 219800 erhaltenen InsulinprÏparates werden in 2 Liter 0,5%iger Trichlorbutylalkohollösung durch Zusatz von 12, 5 cm3 n-Salzsäure in L¯sung gebracht. Man gibt 1, 3 g Magnesiumchlorid und 15 g Kochsalz zu und versetzt dann mit 500 cm3 einer L¯sung, die 14, 4 g sekundares Natriumphos- phat + 8 cm3 n-Natronlauge in 0, 5 % iger Trichlorbutylalkohollosung enthält. Man erhält eine Suspension, die in 1 cm3 40 Einheiten Insulin enthält und ein pu von zirka 7 aufweist. Example: 10 g of an insulin preparation obtained according to Swiss Patent No. 219800 are dissolved in 2 liters of 0.5% trichlorobutyl alcohol solution by adding 12.5 cm3 of normal hydrochloric acid. 1.3 g of magnesium chloride and 15 g of sodium chloride are added and then 500 cm3 of a solution containing 14.4 g of secondary sodium phosphate + 8 cm3 of sodium hydroxide solution in 0.5% trichlorobutyl alcohol are added. A suspension is obtained which contains 40 units of insulin in 1 cm3 and has a pu of approximately 7. Das so erhaltene protrahierend wirkende Insulinpräparat l¯st sich auf Zusatz von Salzsäure. Aus dieser Losung fällt Natron- lauge einen Niederschlag aus, der bei weiterem Zusatz von Lauge wieder in Lösung geht. The protracting insulin preparation obtained in this way can be obtained by adding hydrochloric acid. A precipitate separates out of this solution, caustic soda, which goes back into solution with further addition of caustic. PATENTANSPRUCH : Verfahren zur Herstellung eines PrÏparates aus dem blutzuckersenkenden Hormon der Bauspeiohel'drüse,dadurch gekennzeichnet, dass man das nach dem Schweizer Patent Nr. 219800 erhaltene Insulinpräparat mit Magnesiumehlorid, welches in Wasser gelât ist, umsetzt. PATENT CLAIM: Process for the production of a preparation from the blood sugar lowering hormone of the Bauspeiohel'drüse, characterized in that the insulin preparation obtained according to Swiss Patent No. 219800 is reacted with magnesium chloride, which is dissolved in water. Die so erhaltene Suspension lost sich auf Zusatz von Salzsaure. Aus dieser Losung fällt Natronlauge einen Niederschlag aus, der bei weiterem Zusatz von Lauge wieder in Lösung geht. The suspension thus obtained dissolves on the addition of hydrochloric acid. From this solution, sodium hydroxide solution separates out a precipitate, which goes back into solution with further addition of caustic solution.
CH235478D 1938-06-29 1939-06-29 Process for the production of a preparation from the blood sugar lowering hormone of the pancreas. CH235478A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE235478X 1938-06-29
CH227032T 1939-06-29

Publications (1)

Publication Number Publication Date
CH235478A true CH235478A (en) 1944-11-30

Family

ID=25727052

Family Applications (1)

Application Number Title Priority Date Filing Date
CH235478D CH235478A (en) 1938-06-29 1939-06-29 Process for the production of a preparation from the blood sugar lowering hormone of the pancreas.

Country Status (1)

Country Link
CH (1) CH235478A (en)

Similar Documents

Publication Publication Date Title
CH235478A (en) Process for the production of a preparation from the blood sugar lowering hormone of the pancreas.
CH223228A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH223224A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH163443A (en) Process for the production of a highly concentrated aqueous solution of a salt of 3,5-dibromo-4-pyridone-N-acetic acid.
CH223227A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH223221A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH223225A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH108488A (en) Process for the preparation of an acridinium compound.
CH149252A (en) Process for the preparation of 4-glycolylamino-3'-amino-4'-oxy-arsenobenzene.
CH105813A (en) Process for the preparation of a complex silver compound of thiodiglycolic acid.
CH223223A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH223220A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH162658A (en) Process for the preparation of the sodium salt of an arsenic complex compound of catechinaric acid.
CH203606A (en) Process for the production of a new azo dye.
CH162656A (en) Process for the preparation of the sodium salt of a bismuth complex compound of catechinaric acid.
CH223229A (en) Process for the production of a protracted preparation from the blood sugar lowering hormone of the pancreas.
CH151191A (en) Process for the preparation of 4-glycolylamino-3'-amino-4'-oxy-arsenobenzene.
CH185834A (en) Process for the production of a new azo dye.
CH167953A (en) Process for the preparation of a mercury compound of podophyllin.
CH211026A (en) Process for the production of a new azo dye.
CH162037A (en) Process for the preparation of a non-coloring thio derivative of phenol.
CH192302A (en) Process for the preparation of an aqueous solution of 1-phenyl-2,3-dimethyl-4-methylamino-5-pyrazolone-4-methanesulfonic acid morphine.
CH193080A (en) Process for the production of a new dye.
CH203607A (en) Process for the production of a new azo dye.
CH180883A (en) Method of creating a therapeutically valuable compound.